Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 13(1): 21785, 2023 12 08.
Article in English | MEDLINE | ID: mdl-38066065

ABSTRACT

The development of facial expressions with sensing information is progressing in multidisciplinary fields, such as psychology, affective computing, and cognitive science. Previous facial datasets have not simultaneously dealt with multiple theoretical views of emotion, individualized context, or multi-angle/depth information. We developed a new facial database (RIKEN facial expression database) that includes multiple theoretical views of emotions and expressers' individualized events with multi-angle and depth information. The RIKEN facial expression database contains recordings of 48 Japanese participants captured using ten Kinect cameras at 25 events. This study identified several valence-related facial patterns and found them consistent with previous research investigating the coherence between facial movements and internal states. This database represents an advancement in developing a new sensing system, conducting psychological experiments, and understanding the complexity of emotional events.


Subject(s)
Emotions , Facial Expression , Humans , Movement , Face , Databases, Factual
2.
J Clin Biochem Nutr ; 73(3): 214-220, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37970548

ABSTRACT

Fibrosis, induced by reactive oxygen species (ROS) production in neutrophils, has harmful effects on the liver and various other organs. However, little is known about the association between liver fibrosis and ROS levels in neutrophils in the general population. This large-scale epidemiological study aimed to determine the association between liver fibrosis and neutrophil-generated ROS levels according to age and sex in the general population. This cross-sectional study included 1,000 participants from a district health promotion project. Participants were grouped based on sex (male; female) and age (young, <65 years; old, ≥65 years). The four groups were as follows: male, young (n = 289); male, old (n = 100); female, young (n = 425); and female, old (n = 186). Liver fibrosis was assessed using the fibrosis 4 (FIB-4) index, aspartate aminotransferase-to-platelet ratio index (APRI), and non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS). Basal and stimulated ROS were considered in the analysis. Multiple linear analyses showed (1) significant positive correlations between all liver fibrosis scores and basal ROS in the young groups, and (2) significant negative correlations between NFS and stimulated ROS in females. Preventing liver fibrosis through neutrophil-related immune system enhancement may avert the development of lifestyle-related diseases and infections.

3.
Int J Mol Sci ; 24(17)2023 Aug 30.
Article in English | MEDLINE | ID: mdl-37686272

ABSTRACT

The association between liver fibrosis and oral or gut microbiota has been studied before. However, epidemiological studies in the general population are limited owing to the difficulty of noninvasive liver-fibrosis assessment. FibroScan-asparate aminotransferase (FAST) scores can be used to accurately and non-invasively evaluate liver fibrosis. This study aimed to determine the association between liver fibrosis and oral or gut microbiota using the FAST score in the general population. After propensity score matching of 1059 participants based on sex, age, body mass index, homeostasis model assessment of insulin resistance, and triglyceride levels, 125 (non-liver-fibrosis group, 100; liver fibrosis group, 25) were included. The diversity of gut microbiota differed significantly between the two groups; however, no significant differences were noted in their oral microbiota. The liver fibrosis group showed an increase in the relative abundance of Fusobacteria strains and a decrease in the relative abundance of Faecalibacterium, with the presence of Fusicatenibacter in the gut microbiota. Feacalibacterium was not identified as an independent factor of liver fibrosis in adjusting the fatty liver index. In the general population, gut microbiota may be more involved in liver fibrosis than oral microbiota.


Subject(s)
Gastrointestinal Microbiome , Microbiota , Humans , Aspartate Aminotransferases , East Asian People , Liver Cirrhosis/diagnostic imaging
4.
J Biochem ; 153(3): 257-66, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23225597

ABSTRACT

We previously reported a novel pathway for the biosynthesis of phosphatidylinositol in mycobacteria via phosphatidylinositol phosphate (PIP) [Morii H., Ogawa, M., Fukuda, K., Taniguchi, H., and Koga, Y (2010) J. Biochem. 148, 593-602]. PIP synthase in the pathway is a promising target for the development of new anti-mycobacterium drugs. In the present study, we evaluated the characteristics of the PIP synthase of Mycobacterium tuberculosis. Four types of compounds were chemically synthesized based on the assumption that structural homologues of inositol 1-phosphate, a PIP synthase substrate, would act as PIP synthase inhibitors, and the results confirmed that all synthesized compounds inhibited PIP synthase activity. The phosphonate analogue of inositol 1-phosphate (Ino-C-P) had the greatest inhibitory effect among the synthesized compounds examined. Kinetic analysis indicated that Ino-C-P acted as a competitive inhibitor of inositol 1-phosphate. The IC(50) value for Ino-C-P inhibition of the PIP synthase activity was estimated to be 2.0 mM. Interestingly, Ino-C-P was utilized in the same manner as the normal PIP synthase substrate, leading to the synthesis of a phosphonate analogue of PIP (PI-C-P), which had a structure similar to that of the natural product, PIP. In addition, PI-C-P had high inhibitory activity against PIP synthase.


Subject(s)
Bacterial Proteins/metabolism , CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase/metabolism , Inositol Phosphates/metabolism , Mycobacterium tuberculosis/metabolism , Bacterial Proteins/antagonists & inhibitors , Biocatalysis/drug effects , Biosynthetic Pathways/drug effects , CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase/antagonists & inhibitors , Chromatography, Thin Layer , Dose-Response Relationship, Drug , Hydrogen-Ion Concentration , Inositol Phosphates/chemistry , Inositol Phosphates/pharmacology , Kinetics , Magnesium/pharmacology , Manganese/pharmacology , Mass Spectrometry , Molecular Structure , Mycobacterium tuberculosis/enzymology , Phosphatidylinositol Phosphates/chemistry , Phosphatidylinositol Phosphates/metabolism , Phosphatidylinositols/chemistry , Phosphatidylinositols/metabolism , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...